Clinicopathological Features of Desmoplastic Medulloblastoma: Impact of Cochlear Nucleus Contact

Grammel et al. Suppl. Figure 1 a b CN contact (n=21) CN contact (n=21) p=<0.0001 p=0.287 No CN contact (n=42) No CN contact (n=42) 100 40 80 30 60 Survival [%] Case density [%] 20 40 10 20 0 0 0 4 5 1 2 3 6 7 8 0-3 3-6 6-9 9-12 12-15 15-18 18-20 Age [years] Follow up [years] c d Cases w/ residual disease [%] Cases w/ macro. metastases [%] Cases w/o residual disease [%] Cases w/o macro. metastases [%] p=0.1531 p=0.3688 100 100 80 80 60 60 Frequency [%] Frequency [%] 40 40 20 20 0 0 Cases w/ CN contact (n=20) Cases w/ CN contact (n=19) Cases w/o CN contact (n=38) Cases w/o CN contact (n=33) Supplementary Figure 1: Clinicopathological features of desmoplastic medulloblastoma (MB). Age distribution of MB with contact (n=21) and without contact (n=42) to the cochlear nucleus (CN) in our tumor cohort (n=63) (a). Kaplan-Meier analysis of MB with and without contact to the CN (b). Metastatic status (c) and residual disease incidence (d) in MB with and without contact to the CN. Reduced case numbers in graphs for metastatic and residual disease status are due to unavailibility of the respective data.

Clinicopathological Features of Desmoplastic Medulloblastoma: Impact of Cochlear Nucleus Contact

Clinicopathological Features of Desmoplastic Medulloblastoma: Impact of Cochlear Nucleus Contact

Presentation Transcript

Pöschl et al., Suppl. Figure 1

Suppl Figure 1.

Daniel et al Suppl . Fig . 1

Suppl. Figure 1

SUPPL FIGURE 1

Suppl. Figure 1

Suppl . Figure 1

Suppl Figure 1

Suppl Figure 1

Suppl. Figure 1

Gesell et al., Suppl. Fig. 1

Kuhlmann et al. Suppl. Figure 1

Suppl Figure 1

Suppl. Figure 1:

Suppl. Figure 1

Suppl. Figure 1

Suppl. Figure 1

Biajoux et al. Suppl. Figure 1

Suppl. figure 1

Jungwirth et al. Suppl. Fig. 1

Suppl. Figure 1

Suppl. Figure 1